Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 1
1972 1
1973 1
1974 1
1975 4
1976 2
1977 2
1978 7
1979 2
1980 3
1981 3
1982 1
1983 2
1984 4
1987 2
1988 1
1990 5
1991 1
1992 1
1993 3
1995 2
1996 4
1997 4
1998 4
1999 3
2000 7
2002 2
2003 5
2004 5
2005 2
2006 4
2007 2
2008 4
2009 5
2010 5
2011 14
2012 8
2013 6
2014 5
2015 6
2016 4
2017 16
2018 5
2019 6
2020 6
2021 8
2022 7
2023 10
2024 10
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

208 results

Results by year

Filters applied: . Clear all
Page 1
Atopic Dermatitis (Eczema) Guidelines 2023: Highlights.
De Benedetto A, Boguniewicz M, Ong PY, Chu DK, Schneider LC. De Benedetto A, et al. Among authors: schneider lc. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2955-2965. doi: 10.1016/j.jaip.2024.08.052. Epub 2024 Sep 7. J Allergy Clin Immunol Pract. 2024. PMID: 39251015 Review.
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials.
Chu AWL, Wong MM, Rayner DG, Guyatt GH, Díaz Martinez JP, Ceccacci R, Zhao IX, McMullen E, Srivastava A, Wang J, Wen A, Wang FC, Brignardello-Petersen R, Izcovich A, Oykhman P, Wheeler KE, Wang J, Spergel JM, Singh JA, Silverberg JI, Ong PY, O'Brien M, Martin SA, Lio PA, Lind ML, LeBovidge J, Kim E, Huynh J, Greenhawt M, Gardner DD, Frazier WT, Ellison K, Chen L, Capozza K, De Benedetto A, Boguniewicz M, Smith Begolka W, Asiniwasis RN, Schneider LC, Chu DK. Chu AWL, et al. Among authors: schneider lc. J Allergy Clin Immunol. 2023 Dec;152(6):1470-1492. doi: 10.1016/j.jaci.2023.08.029. Epub 2023 Sep 9. J Allergy Clin Immunol. 2023. PMID: 37678577 Free article.
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Paller AS, Simpson EL, Siegfried EC, Cork MJ, Wollenberg A, Arkwright PD, Soong W, Gonzalez ME, Schneider LC, Sidbury R, Lockshin B, Meltzer S, Wang Z, Mannent LP, Amin N, Sun Y, Laws E, Akinlade B, Dillon M, Kosloski MP, Kamal MA, Dubost-Brama A, Patel N, Weinreich DM, Yancopoulos GD, O'Malley JT, Bansal A; participating investigators. Paller AS, et al. Among authors: schneider lc. Lancet. 2022 Sep 17;400(10356):908-919. doi: 10.1016/S0140-6736(22)01539-2. Lancet. 2022. PMID: 36116481 Free article. Clinical Trial.
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.
NIAID-Sponsored Expert Panel; Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM. NIAID-Sponsored Expert Panel, et al. Among authors: schneider lc. J Allergy Clin Immunol. 2010 Dec;126(6 Suppl):S1-58. doi: 10.1016/j.jaci.2010.10.007. J Allergy Clin Immunol. 2010. PMID: 21134576 Free PMC article.
Combining anti-IgE with oral immunotherapy.
Lin C, Lee IT, Sampath V, Dinakar C, DeKruyff RH, Schneider LC, Nadeau KC. Lin C, et al. Among authors: schneider lc. Pediatr Allergy Immunol. 2017 Nov;28(7):619-627. doi: 10.1111/pai.12767. Epub 2017 Sep 7. Pediatr Allergy Immunol. 2017. PMID: 28782296 Review.
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Pongracic JA, Gagnon R, Sussman G, Siri D, Oriel RC, Brown-Whitehorn TF, Anvari S, Berger WE, Bird JA, Chan ES, Chinthrajah RS, Chong HJ, Fineman SM, Fleischer DM, Gonzalez-Reyes E, Kim EH, Lanser BJ, MacGinnitie A, Mehta H, Petroni D, Rupp N, Schneider LC, Scurlock AM, Sher LD, Shreffler WG, Sindher SB, Wood R, Yang WH, Sampson HA, Bois T, Green TD, Campbell DE, Bee KJ, Bégin P. Pongracic JA, et al. Among authors: schneider lc. J Allergy Clin Immunol Pract. 2025 May;13(5):1190-1200.e3. doi: 10.1016/j.jaip.2025.02.024. Epub 2025 Feb 27. J Allergy Clin Immunol Pract. 2025. PMID: 40023371 Free article. Clinical Trial.
208 results